When we think of the age-old adage about getting old, "What new ache or pain will each new day bring?" we often imagine ...

A Utah woman in her 60s had glaucoma and hoped to protect her eye health through better nutrition. So she took a daily 20-mg ...

AI enhances home OCT imaging to track wet AMD disease activity, enabling personalized patient management and improved ...

Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as ...

Mynzepli (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal ...

In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...

Advanz Pharma and Alvotech announced AVT06, a biosimilar to Eylea, was approved for neovascular age-related macular ...

Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases -- CLS-AX ...

Optimising wet AMD care is not just clinically sound - it empowers patients, improves outcomes, and delivers savings for the NHS ...

The global dry age-related macular degeneration AMD market size US$ 7,989.1 million in 2021. The global dry age-related macular degeneration AMD market is projected to grow to US$ 20,279.1 million by ...